Clinical Trial Update: RASi for Preventing Postoperative Recurrence of Stage II/III Colon Cancer

View source ↗

Summary

Clinical trial evaluating RAS inhibitors to prevent postoperative recurrence in stage II/III colon cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: Fudan University | Conditions: Colon Cancer (Stage II &Amp;Amp; III) | Status: COMPLETED